After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Immunogen, Inc. is $8.25B. A total of 4.51 million shares were traded on the day, compared to an average of 8.21M shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, IMGN has seen 18 BUY and 8 SELL insider trades, representing the acquisition of 450,379 and the disposition of 530,944 shares. Over the last 12 months, there were 61 BUYs and 20 SELLs from insiders. Insiders purchased 4,368,089 shares during that period but sold 4,275,583.
In the most recent transaction, Wingrove Theresa sold 187,667 shares of IMGN for 29.64 per share on Jan 16. After the transaction, the SVP OF REGULATORY AFFAIRS now owns 3,426 company shares. In a previous transaction on Dec 26, Lentini Renee sold 6,548 shares at 29.74 per share. IMGN shares that VP & PRIN ACCTG OFFICER owns now total 8,452.
Among the insiders who sold shares, Wingrove Theresa disposed of 117,445 shares on Dec 15 at a per-share price of $29.40. This resulted in the SVP OF REGULATORY AFFAIRS holding 2,811 shares of IMGN after the transaction. In another insider transaction, Wingrove Theresa sold 164,424 shares at $28.95 per share on Nov 30. Company shares held by the SVP OF REGULATORY AFFAIRS now total 2,811.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for IMGN in the last 3 months, the mean price target is $29.34 with high estimates of $31.26 and low estimates of $19.00. In terms of 52-week highs and lows, IMGN has a high of $30.13 and a low of $3.61.
As of this writing, IMGN has an earnings estimate of $0.13 per share for the current quarter. EPS was calculated based on a consensus of 14 estimates, with a high estimate of $0.22 per share and a lower estimate of $0.07. The company reported an EPS of -$0.02 in the last quarter, which was 85.70% higher than expectations of -$0.14.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. IMGN’s latest balance sheet shows that the firm has $478.75M in Cash & Short Term Investments as of fiscal 2021. There were $18.78M in debt and $100.94M in liabilities at the time. Its Book Value Per Share was $2.11, while its Total Shareholder’s Equity was $325.59M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMGN is Buy with a score of 3.15.
